In 2021, there were around 118 deaths per 100,000 population due to chronic obstructive pulmonary disease (COPD) in Oceania. This was the highest rate of death due to COPD worldwide. Globally, there were around 45 COPD deaths per 100,000 population in 2021.
In 2021, there were around 1.32 million deaths in East Asia due to chronic obstructive pulmonary disease (COPD). That year, there were a total of 3.72 million deaths due to COPD.
https://digital.nhs.uk/about-nhs-digital/terms-and-conditionshttps://digital.nhs.uk/about-nhs-digital/terms-and-conditions
Mortality from bronchitis and emphysema and other chronic obstructive pulmonary disease (ICD-10 J40-J44 equivalent to ICD-9 490-492, 496) To reduce deaths from bronchitis, emphysema and other chronic obstructive pulmonary disease. Legacy unique identifier: P00174
In 2021, the death rate from chronic obstructive pulmonary disease (COPD) among women aged 45 years and older was around 89 per 100,000 population, while the death rate for men was about 105 per 100,000 population. This statistic shows the age-adjusted death rate from COPD among U.S. adults aged 45 years and older from 1999 to 2021, by gender.
In 2021, the death rate from chronic obstructive pulmonary disease (COPD) among those aged 45 years and older was around 96 per 100,000 population. This was a decrease from a rate of 124 per 100,000 population in the year 1999. This statistic shows the age-adjusted death rate from COPD among U.S. adults from 1999 to 2021.
In 2021, there were almost 171 deaths per 100,000 population due to chronic obstructive pulmonary disease (COPD) among adults aged 45 years and older in Arkansas, the highest rate of any U.S. state. This statistic shows the death rate from COPD among U.S. adults in 2021, by state.
The number of deaths from obstructive pulmonary disease per 100,000 inhabitants in Spain in 2022 was highest in the autonomous community of Ceuta. In that year, the mortality rate from COPD in that region amounted to 34.49 deaths per 100,000 inhabitants. The Balearic Islands and Murcia followed, with a COPD mortality rate of 28.87 and 27.58 people per 100,000 population, respectively.
https://digital.nhs.uk/about-nhs-digital/terms-and-conditionshttps://digital.nhs.uk/about-nhs-digital/terms-and-conditions
Mortality from bronchitis and emphysema (ICD-10 J40-J43 equivalent to ICD-9 490-492). This indicator is included for continuity with previous Compendia. However, it is recommended that the indicator ‘mortality from bronchitis, emphysema and other chronic obstructive pulmonary disease’ be used instead, especially when analysing trend data. To reduce deaths from bronchitis and emphysema. Legacy unique identifier: P00169
An analysis of death certificate data from 1999 and 2019 in the United States, revealed an increase in the rate of deaths related to chronic obstructive pulmonary disease (COPD) among women aged 25 years and older in the Midwest and the South. In 1999, the rate of deaths related to COPD among women in the South was 54.5 per 100,000 population, while in 2019 this death rate was 59.3. This graph shows the rate of deaths related to COPD among U.S. women aged 25 years and above in 1999 and 2019, by region.
In 2020, around 14 percent of all deaths among those in the mining industry in the United States died from chronic obstructive pulmonary disease (COPD). This statistic shows the percentage of deaths in select industries in the United States that were from chronic obstructive pulmonary disease in 2020.
An analysis of death certificate data from 1999 and 2019 in the United States, revealed a decrease in the rate of deaths related to chronic obstructive pulmonary disease (COPD) among men aged 25 years and older in all regions of the United States. In 1999, the rate of deaths related to COPD among men in the South was 92.4 per 100,000 population, while in 2019 this death rate was 69. This graph shows the rate of deaths related to COPD among U.S. men aged 25 years and above in 1999 and 2019, by region.
An analysis of death certificate data from 1999 and 2019 in the United States, revealed an increase in the rate of deaths related to chronic obstructive pulmonary disease (COPD) among women aged 25 years and older in micropolitan areas. In 1999, the rate of deaths related to COPD among women in micropolitan areas was 56.8 per 100,000 population, while in 2019 this death rate was 71.3. This graph shows the rate of deaths related to COPD among U.S. women aged 25 years and above in 1999 and 2019, by urban-rural status.
Death rate has been age-adjusted by the 2000 U.S. standard population. Single-year data are only available for Los Angeles County overall, Service Planning Areas, Supervisorial Districts, City of Los Angeles overall, and City of Los Angeles Council Districts.Chronic obstructive pulmonary disease (COPD) refers to a group of diseases, including emphysema and chronic bronchitis, that create airflow blockages in the lungs. Exposure to tobacco smoke is an important risk factor for COPD. Cities and communities can take an active role in curbing tobacco use and reducing COPD by adopting policies to regulate tobacco retail; reducing exposure to secondhand smoke in outdoor public spaces, such as parks, restaurants, or in multi-unit housing; and improving access to tobacco cessation programs and other preventive services.For more information about the Community Health Profiles Data Initiative, please see the initiative homepage.
In 2021, the number of deaths due to chronic obstructive pulmonary disease (COPD) in Spain amounted to around 11.3 thousand, down from around 12.7 thousand deaths registered a year earlier. The highest number of deceases stemming from this lung condition reached over 17 thousand at the beginning of the period.
In 2020, around 13 percent of all deaths among those whose occupation was in the military in the United States died from chronic obstructive pulmonary disease (COPD). This statistic shows the percentage of deaths in select occupations in the United States that were from chronic obstructive pulmonary disease in 2020.
An analysis of death certificate data from 1999 and 2019 in the United States, revealed a decrease in the rate of deaths related to chronic obstructive pulmonary disease (COPD) among men aged 25 years and older in micropolitan areas. In 1999, the rate of deaths related to COPD among men in micropolitan areas was 102.5 per 100,000 population, while in 2019 this death rate was 87. This graph shows the rate of deaths related to COPD among U.S. men aged 25 years and above in 1999 and 2019, by urban-rural status.
This statistic shows the rate of death from Chronic Obstructive Pulmonary Disease (COPD) in the U.S. in 2015, by urban-rural status. In that year, around 47 people per 100,000 population in small metropolitan counties died from COPD.
http://reference.data.gov.uk/id/open-government-licencehttp://reference.data.gov.uk/id/open-government-licence
This data shows premature deaths (Age under 75) from Respiratory Disease, numbers and rates by gender, as 3-year moving-averages.
Smoking is the major cause of chronic obstructive pulmonary disease (COPD), one of the major Respiratory diseases. COPD (which includes chronic bronchitis and emphysema) results in many hospital admissions. Respiratory diseases can also be caused by environmental factors (such as pollution, or housing conditions) and influenza. Respiratory disease mortality rates show a socio-economic gradient.
Directly Age-Standardised Rates (DASR) are shown in the data, where numbers are sufficient, so that death rates can be directly compared between areas. The DASR calculation applies Age-specific rates to a Standard (European) population to cancel out possible effects on crude rates due to different age structures among populations, thus enabling direct comparisons of rates.
A limitation on using mortalities as a proxy for prevalence of health conditions is that mortalities may give an incomplete view of health conditions in an area, as ill-health might not lead to premature death.
Data source: Public Health England, Public Health Outcomes Framework (PHOF) indicator 4.07i. This data is updated annually.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Background: Chronic obstructive pulmonary disease (COPD) is among leading causes of death globally. Exposure to outdoor pollution is an important cause for increased mortality and morbidity. This study presents a systemic review regarding the impact of outdoor pollution on COPD mortality in South Asia and China.
Methods: A systematic search was conducted from 1990 to June 30th 2020 in English electronic databases: PubMed, Google Scholar and CDSR (Cochrane Database of Systematic Reviews) following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The following terms were used: Chronic Obstructive Pulmonary disease OR COPD OR Chronic Bronchitis OR Emphysema OR COPD Deaths OR Chronic Obstructive Lung Disease OR Airflow Obstruction OR Chronic Airflow Obstruction OR Airflow Obstruction, Chronic OR Bronchitis, Chronic AND Mortality OR Death OR Deceased AND Outdoor pollution, ambient pollution was conducted.
Results: Out of 1899 papers screened only 17 were found eligible to be included. Subjects with COPD exposed to higher levels of outdoor air pollution had a 49% higher risk of death as compared to COPD subjects exposed to lower levels of outdoor air pollution. When taking common air pollutants individually into consideration, PM10 had an odds ratio (OR) of 1.99 respectively at CI 95%, whereas SO2 had OR of 1.8 at 95% CI, and NO2 had an OR of 1.23 OR at 95% CI. These values suggest that there is an effect of outdoor pollution on COPD but not to a significant level.
Conclusion: Despite heterogeneity across selected studies, individuals exposed to outdoor pollutants were found to be at risk of COPD mortality. Though it appears to have risk, COPD mortality was not significantly associated with outdoor pollutants. Controlling air pollution can substantially decrease the risk of COPD in South Asia and China. Further researches including more prospective and longitudinal studies are urgently needed in COPD sub-groups.
The projected number of patients suffering from chronic obstructive pulmonary disease (COPD) is expected to reach about three million by 2024. In that year, the population growth is forecasted to decline slightly but there will be an increase of the elderly over 65 years old. Alongside with the population structure, the prevalence of diseases changes proportionally.
In 2021, there were around 118 deaths per 100,000 population due to chronic obstructive pulmonary disease (COPD) in Oceania. This was the highest rate of death due to COPD worldwide. Globally, there were around 45 COPD deaths per 100,000 population in 2021.